hydroxyurea and glutamine
hydroxyurea has been researched along with glutamine in 19 studies
Research
Studies (19)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (10.53) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (5.26) | 29.6817 |
2010's | 9 (47.37) | 24.3611 |
2020's | 7 (36.84) | 2.80 |
Authors
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Pardee, AB | 1 |
Dean, A; Erard, F; Schechter, AN | 1 |
Ansari, J; Gavins, FNE; Moufarrej, YE; Pawlinski, R | 1 |
Quinn, CT | 1 |
Bellevue, R; Blake, OA; Gordeuk, VR; Guillaume, E; Hsu, LL; Kanter, J; Lanzkron, S; Lasky, JL; Miller, ST; Neumayr, LD; New, TN; Niihara, Y; Osunkwo, I; Panosyan, EH; Razon, RL; Sadanandan, S; Sarnaik, S; Sieger, L; Smith, WR; Stark, CW; Tran, LT; Vichinsky, EP; Viswanathan, K | 1 |
Ataga, KI | 1 |
Hoppe, C; Neumayr, L | 1 |
Carden, MA; Little, J | 1 |
Howell, CM; Monus, T | 1 |
Gordeuk, VR; Han, J; Saraf, SL | 1 |
Hehre, RJ | 1 |
Rungkitwattanakul, D; Singh, D; Weaver, SB | 1 |
Fasipe, TA; Kavanagh, PL; Wun, T | 1 |
Lee, MT; Ogu, UO | 1 |
Ataga, KI; Desai, PC; Rai, P | 1 |
Jonassaint, CR; Kane-Gill, SL; Newman, TV; Novelli, EM; Suh, K; Yang, J | 1 |
Reviews
12 review(s) available for hydroxyurea and glutamine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease.
Topics: Anemia, Sickle Cell; Antisickling Agents; Cell Communication; Cerebrovascular Disorders; Disease Progression; Glutamine; Hemoglobins; Humans; Hydroxyurea; Inflammation; Mutation; Neutrophils; Quality of Life | 2018 |
l-Glutamine for sickle cell anemia: more questions than answers.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Child; Child, Preschool; Drug Approval; Female; Glutamine; Humans; Hydroxyurea; Male; United States; United States Food and Drug Administration | 2018 |
Sickle Cell Disease: Monitoring, Current Treatment, and Therapeutics Under Development.
Topics: Anemia, Sickle Cell; Antisickling Agents; Child; Clinical Trials as Topic; Erythrocyte Transfusion; Glutamine; Humans; Hydroxyurea; Monitoring, Physiologic; Stem Cell Transplantation | 2019 |
Emerging disease-modifying therapies for sickle cell disease.
Topics: Anemia, Sickle Cell; Antioxidants; Antisickling Agents; Blood Coagulation; Clinical Trials as Topic; Drug Approval; Erythrocytes; Fetal Hemoglobin; Glutamine; Hematopoietic Stem Cell Transplantation; Hemoglobin, Sickle; Humans; Hydroxyurea; Inflammation; Platelet Activation; Polymers; United States; United States Food and Drug Administration | 2019 |
Current and emerging treatments for sickle cell disease.
Topics: Acute Chest Syndrome; Acute Disease; Analgesics, Opioid; Anemia, Sickle Cell; Anti-Bacterial Agents; Antisickling Agents; Chronic Disease; Disease Progression; Erythrocyte Transfusion; Fluid Therapy; Genetic Therapy; Glutamine; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Infant, Newborn; Infection Control; Infections; Mesenteric Ischemia; Neonatal Screening; Oxygen Inhalation Therapy; Pain Management; Patient Education as Topic; Pneumococcal Infections; Pneumococcal Vaccines; Stroke | 2019 |
Systematic Review of Crizanlizumab: A New Parenteral Option to Reduce Vaso-occlusive Pain Crises in Patients with Sickle Cell Disease.
Topics: Anemia, Sickle Cell; Animals; Antibodies, Monoclonal, Humanized; Glutamine; Humans; Hydroxyurea; P-Selectin; Pain; Randomized Controlled Trials as Topic | 2020 |
Managing patients with sickle cell disease in primary care.
Topics: Administration, Oral; Anemia, Sickle Cell; Antibodies, Monoclonal, Humanized; Antisickling Agents; Blood Transfusion; Evidence-Based Medicine; Female; Glutamine; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Iodine Isotopes; Maintenance Chemotherapy; Male; Monitoring, Physiologic; Practice Guidelines as Topic; Primary Health Care | 2020 |
Contemporary Management and Prevention of Vaso-Occlusive Crises (VOCs) in Adults With Sickle Cell Disease.
Topics: Adult; Anemia, Sickle Cell; Glutamine; Hospitalization; Humans; Hydroxyurea | 2023 |
Sickle Cell Disease: A Review.
Topics: Adult; Anemia, Sickle Cell; Antibodies, Monoclonal, Humanized; Antisickling Agents; Benzaldehydes; Child; Glutamine; Hematologic Agents; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Infant, Newborn; Neonatal Screening; Pain; Pyrazines; Pyrazoles; Transition to Adult Care; United States | 2022 |
Sickle cell disease in the new era: advances in drug treatment.
Topics: Anemia, Sickle Cell; Fetal Hemoglobin; Glutamine; Hemoglobin, Sickle; Hemoglobins; Humans; Hydroxyurea; Nitric Oxide; Oxidants; Oxygen; United States | 2022 |
The Evolving Landscape of Drug Therapies for Sickle Cell Disease.
Topics: Anemia, Sickle Cell; Genetic Therapy; Glutamine; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea | 2022 |
Trials
1 trial(s) available for hydroxyurea and glutamine
Article | Year |
---|---|
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.
Topics: Administration, Oral; Adolescent; Adult; Anemia, Sickle Cell; Antisickling Agents; beta-Thalassemia; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Glutamine; Humans; Hydroxyurea; Intention to Treat Analysis; Male; Middle Aged; Pain; Pain Management; Young Adult | 2018 |
Other Studies
6 other study(ies) available for hydroxyurea and glutamine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A restriction point for control of normal animal cell proliferation.
Topics: Animals; Autoradiography; Cell Differentiation; Cell Division; Cell Line; Cell Survival; Cells, Cultured; Colchicine; Cricetinae; Culture Media; DNA; DNA Replication; Glutamine; Hydroxyurea; Isoleucine; Kidney; Kinetics; Mitosis; Thymidine; Tritium | 1974 |
Inhibitors of cell division reversibly modify hemoglobin concentration in human erythroleukemia K562 cells.
Topics: Cell Transformation, Neoplastic; Culture Media; Glutamine; Hemin; Hemoglobins; Humans; Hydroxyurea; Isoelectric Focusing; Leukemia, Erythroblastic, Acute; Time Factors | 1981 |
New and experimental agents for sickle cell disease.
Topics: Anemia, Sickle Cell; Antisickling Agents; Combined Modality Therapy; Drug Discovery; Erythrocyte Transfusion; Glutamine; Humans; Hydroxyurea | 2018 |
Use of Disease-Modifying Treatments in Patients With Sickle Cell Disease.
Topics: Acute Chest Syndrome; Adult; Anemia, Sickle Cell; Child; Cross-Sectional Studies; Female; Glutamine; Humans; Hydroxyurea; Inpatients; Male | 2023 |